


Ask a doctor about a prescription for IBUDOL PEDIATRIC 40 mg/mL ORAL SUSPENSION
Package Leaflet: Information for the User
Ibudol Pediatric 40 mg/ml Oral Suspension
Ibuprofen
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Follow the instructions for administration of the medicine contained in this leaflet or as indicated by your doctor or pharmacist.
Contents of the Package Leaflet
Ibudol Pediatric contains ibuprofen and belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs).
This medicine is indicated for the symptomatic treatment of fever and occasional pain of mild to moderate intensity in children from 3 months to 12 years.
Do not takeIbudol Pediatricif:
Warnings and Precautions
Allergic reactions to this medicine, such as respiratory problems, swelling of the face and neck (angioedema), and chest pain, have been reported with ibuprofen. Stop using Ibudol Pediatric immediately and contact your doctor or medical emergency services if you observe any of these signs.
Consult your doctor or pharmacist before starting to take this medicine:
It is important to use the smallest dose that relieves-controls the pain and not to take this medicine for longer than necessary to control your symptoms.
Skin Reactions
Be especially careful with Ibudol Pediatric:
Severe skin reactions, such as exfoliative dermatitis, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), and acute generalized exanthematous pustulosis (AGEP), have been reported in association with ibuprofen treatment. Discontinue treatment with Ibudol Pediatric and seek immediate medical attention if you notice any symptoms related to these severe skin reactions described in section 4.
Cardiovascular Precautions
Anti-inflammatory/analgesic medicines like ibuprofen may be associated with a small increased risk of heart attack or stroke, especially when used in high doses. Do not exceed the recommended dose or treatment duration.
You should discuss your treatment with your doctor or pharmacist before taking ibuprofen if:
Similarly, this type of medicine may cause fluid retention, especially in patients with heart failure and/or high blood pressure (hypertension).
Children and Adolescents
There is a risk of kidney damage in dehydrated children.
Precautions during Pregnancy and in Women of Childbearing Age
Because the administration of ibuprofen has been associated with an increased risk of congenital anomalies/abortions, its administration is not recommended during the first and second trimester of pregnancy, unless it is strictly necessary. In these cases, the dose and duration will be limited to the minimum possible.
In the third trimester, the administration of this medicine is contraindicated.
For women of childbearing age, it should be taken into account that ibuprofen has been associated with a decrease in fertility.
Infections
Ibudol Pediatric may mask the signs of an infection, such as fever and pain. Consequently, this medicine may delay the appropriate treatment of the infection, which may increase the risk of complications. This has been observed in bacterial pneumonia and bacterial skin infections related to chickenpox. If you take this medicine while having an infection and the symptoms of the infection persist or worsen, consult your doctor without delay.
Other Medicines and Ibudol Pediatric
Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medicine.
This medicine may affect or be affected by other medicines. For example:
Other medicines may also affect or be affected by treatment with ibuprofen. Therefore, you should always consult your doctor or pharmacist before using Ibudol Pediatric with other medicines.
Taking ibuprofen may alter the following laboratory tests:
Inform your doctor if you are going to undergo a clinical analysis and are taking or have recently taken ibuprofen.
Taking Ibudol Pediatric with Food, Drinks, and Alcohol
It is recommended to take this medicine with milk or with food, or immediately after eating, to reduce the possibility of stomach upset. Do not take alcohol, as it may increase gastrointestinal side effects.
Pregnancy, Breastfeeding, and Fertility
The use of this medicine is not recommended in women who are trying to become pregnant.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine. You should not take this medicine during pregnancy, especially during the third trimester (see section precautions during pregnancy and in women of childbearing age). It may cause kidney and heart problems in your fetus. It may affect your ability and that of your baby to bleed and delay or prolong labor more than expected. You should not take ibuprofen during the first 6 months of pregnancy unless it is clearly necessary and as indicated by your doctor. If you need treatment during this period or while trying to become pregnant, you should take the minimum dose for the shortest possible time. From the 20th week of pregnancy, ibuprofen may cause kidney problems in your fetus if taken for more than a few days, which may cause low levels of amniotic fluid surrounding the baby (oligohydramnios) or narrowing of a blood vessel (ductus arteriosus) in the baby's heart. If you need treatment for more than a few days, your doctor may recommend additional monitoring.
Although only small amounts of the medicine pass into breast milk, it is recommended not to take ibuprofen for prolonged periods during breastfeeding.
Driving and Using Machines
If you experience dizziness, vertigo, vision changes, or other symptoms while taking this medicine, do not drive or use hazardous machinery. If you only take one dose of ibuprofen or for a short period, it is not necessary to take special precautions.
Ibuprofen may delay your reaction time, which should be taken into account before performing activities that require greater vigilance, such as driving and using machinery.
This applies to a greater extent to the combination with alcohol.
Ibudol Pediatric Contains Maltitol Liquid (E-965), Sodium Benzoate (E-211), Benzyl Alcohol, and Sodium
This medicine contains maltitol liquid. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine. It may produce a mild laxative effect because it contains 500 mg of maltitol liquid per ml of oral suspension. Caloric value: 2.3 kcal/g of maltitol/isomalt.
This medicine contains 1 mg of sodium benzoate in each ml of suspension. Sodium benzoate may increase the risk of jaundice (yellowing of the skin and eyes) in newborns (up to 4 weeks of age).
This medicine contains 0.00017 mg of benzyl alcohol in each ml. Benzyl alcohol may cause allergic reactions. Consult your doctor or pharmacist if you have liver or kidney disease. This is because large amounts of benzyl alcohol can accumulate in the body and cause adverse effects (metabolic acidosis). This medicine should not be used for more than one week in children under 3 years of age unless indicated by your doctor or pharmacist.
This medicine contains sodium:
Doses up to 4 ml per individual dose (included): This medicine contains less than 23 mg of sodium (1 mmol) per ml of oral suspension; that is, it is essentially "sodium-free"
Doses from 4 ml per individual dose: This medicine contains 5.75 mg of sodium (main component of table salt/cooking salt) in each ml of oral suspension. This is equivalent to 2.87% of the maximum recommended daily sodium intake for an adult.
Follow the administration instructions of this medication exactly as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
For occasional use only and for limited periods.
The lowest effective dose should be used for the shortest time necessary to relieve symptoms. If you have an infection, consult a doctor without delay if symptoms (such as fever and pain) persist or worsen (see section 2).
Children from 3 months to 12 years:
The recommended dose of ibuprofen depends on the child's age and weight.
As a general rule, for children from 3 months to 12 years, the recommended daily dose is 20 to 30 mg per kg of body weight, depending on the intensity of the symptoms, and is divided into three doses.
The use of this medication in children under 2 years of age will always be done under medical prescription.
As a guide, the following doses can be followed:
DOSAGE IN CHILDREN | |||
Approximate age | Body weight | Recommended dose per individual dose (x3) | Maximum daily dose (in 24 hours) |
from 3 to 6 months | 5 kg | 0.8 to 1.2 mL | 3.6 mL (144 mg) |
6 kg | 1 to 1.4 mL | 4.2 mL (168 mg) | |
7 kg | 1.2 to 1.6 mL | 4.8 mL (192 mg) | |
from 6 to 12 months | 8 kg | 1.4 to 2 mL | 6 mL (240 mg) |
9 kg | 1.6 to 2.2 mL | 6.6 mL (264 mg) | |
from 12 to 24 months | 10 kg | 1.8 to 2.4 mL | 7.2 mL (288 mg) |
12 kg | 2 to 3 mL | 9 mL (360 mg) | |
from 2 to 3 years | 14 kg | 2.4 to 3.4 mL | 10.2 mL (408 mg) |
from 4 to 5 years | 16 kg | 2.8 to 4 mL | 12 mL (480 mg) |
18 kg | 3 to 4.4 mL | 13.2 mL (528 mg) | |
from 6 to 9 years | 20 kg | 3.4 to 5 mL | 15 mL (600 mg) |
22 kg | 3.8 to 5.4 mL | 16.2 mL (648 mg) | |
24 kg | 4 to 6 mL | 18 mL (720 mg) | |
26 kg | 4.4 to 6.4 mL | 19.2 mL (768 mg) | |
from 10 to 12 years | 28 kg | 4.8 to 7 mL | 21 mL (840 mg) |
30 kg | 5 to 7.4 mL | 22.2 mL (888 mg) | |
32-36 kg | 5.4-6 to 8-9 mL | 24-27 mL (960 - 1080 mg) | |
36-40 kg | 6-6.8 to 9-10 mL | 27-30 mL (1080 - 1200 mg) |
The suspension can also be dosed following a regimen of 4 daily doses. In this case, the maximum daily doses (see last column of the previous table) should not be exceeded in 24 hours. The dose to be administered at each dose, every 6 hours, will be recalculated/reduced proportionally.
The use of this medication is not recommended in children under 3 months or weighing less than 5 kg.
Patients with kidney, liver, or heart disease: should reduce the dose and consult a doctor. Ibuprofen should not be used in patients with severe cardiac, renal, or hepatic failure.
If this medication needs to be used for more than 3 days or if symptoms worsen or do not improve in children from 6 months to 12 years, a doctor should be consulted.
In children aged 3 to 5 months, a doctor should be consulted if symptoms worsen or persist after 24 hours.
Form of administration
Ibudol Pediatric is an oral suspension. It can be administered directly or diluted in water.
A burning sensation in the mouth or throat may occur when taking the oral ibuprofen suspension; make sure the bottle has been shaken well before administering the medication.
Patients with stomach upset should take the medication with milk and/or during meals.
Medication administration is subject to the appearance of pain or fever. As these disappear, the medication should be suspended.
If you take more Ibudol Pediatric than you should
If you have taken more medication than you should, or if a child has accidentally ingested the contents of the container, consult your doctor or pharmacist immediately, or contact the Toxicology Information Service, phone: 91 562 04 20, or go to the nearest hospital to find out about the risk and ask for advice on the measures to be taken.
Normally, symptoms of overdose occur 4 to 6 hours after taking ibuprofen.
Symptoms of an overdose may include nausea, stomach pain, vomiting (which may contain blood), headache, ringing in the ears, confusion, involuntary eye movement, and lack of muscle coordination. At high doses, symptoms of drowsiness, chest pain, palpitations, loss of consciousness, convulsions (mainly in children), weakness, and dizziness, blood in the urine, low potassium levels in the blood, chills, and breathing problems have been reported. Cases of increased blood acidity (metabolic acidosis), decreased body temperature, altered kidney function, stomach and intestinal bleeding, coma, transient loss of breathing (apnea), central nervous system depression, and respiratory system depression may occur. Cardiovascular toxicity (decreased blood pressure, decreased heart rate, and increased heart rate) has also been reported.
If severe poisoning occurs, kidney failure and liver damage may occur. In these cases, the doctor will take the necessary measures.
If you forgot to take Ibudol Pediatric
Do not take a double dose to make up for missed doses. If you forget to take your corresponding dose, take it as soon as you remember. However, if the time of the next dose is very close, skip the missed dose and take the next dose at the usual time.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause adverse effects, although not everyone will experience them.
The incidence of adverse effects is lower in short treatments and if the daily dose is below the maximum recommended dose.
Chest pain, which can be a sign of a potentially serious allergic reaction called Kounis syndrome.
Interrupt treatment with Ibudol Pediatric and seek medical attention immediately if you notice any of the following symptoms:
The frequencies shown below refer to the short-term use of maximum daily doses of up to 1200 mg of oral ibuprofen:
Frequent adverse effects: (may affect up to 1 in 10 people): Gastrointestinal bleeding, especially in elderly patients. Nausea, vomiting, diarrhea, flatulence, dyspepsia (disorder of gastric secretion or motility), constipation, heartburn, abdominal pain, blood in stools, vomiting blood, headache, dizziness or feeling of instability, fatigue.
Uncommon adverse effects: (may affect up to 1 in 100 people): Gastritis, duodenal ulcers, gastric ulcers, skin redness, itching or tingling of the skin, hives, purpura (purple spots on the skin), skin reaction due to light influence, hypersensitivity, paresthesia (sensation of numbness, tingling, or prickling, more frequent in hands, feet, arms, or legs), drowsiness, insomnia, anxiety, hearing disorders, vision changes, rhinitis (inflammation of the nasal mucosa), inflammation of the oral mucosa with ulcer formation (mouth sores), gastrointestinal perforations, hepatitis (inflammation of the liver), liver function abnormalities, and jaundice (yellowing of the skin and eyes), asthma, bronchospasm, dyspnea (difficulty breathing). Interstitial nephritis (kidney disorder), nephrotic syndrome (disorder characterized by protein in the urine and swelling of the body), and renal failure (sudden loss of kidney function), acute renal failure, and papillary necrosis (especially with prolonged use) associated with increased urea.
Rare adverse effects: (may affect up to 1 in 1,000 people): Disorientation or confusion, depression, vertigo, tinnitus (ringing or buzzing in the ears), hearing impairment, reversible toxic amblyopia, liver damage, edema (swelling caused by fluid accumulation in tissues), optic neuritis, anaphylactic reaction (in case of severe generalized hypersensitivity reaction, signs may include facial swelling, tongue and larynx swelling, shortness of breath, tachycardia, hypotension (anaphylaxis, angioedema, or severe shock)), aseptic meningitis (inflammation of the meninges, which are the membranes that protect the brain and spinal cord, not caused by bacteria). In most cases where aseptic meningitis has been reported with ibuprofen, the patient had some form of autoimmune disease (such as systemic lupus erythematosus and other collagen diseases), which was a risk factor. The symptoms of aseptic meningitis observed were neck stiffness, headache, nausea, vomiting, fever, or disorientation. Other adverse effects are decreased platelets, decreased white blood cells (may manifest as frequent infections with fever, chills, or sore throat), decreased red blood cells (may manifest as difficulty breathing and pale skin), neutropenia (decrease in neutrophils), and agranulocytosis (very large decrease in neutrophils), aplastic anemia (bone marrow failure to produce different types of cells), hemolytic anemia (premature destruction of red blood cells). The first symptoms are: fever, sore throat, superficial mouth ulcers, pseudo-flu symptoms, extreme fatigue, bleeding, and bruises of unknown cause.
Very rare adverse effects: (may affect up to 1 in 10,000 people): Pancreatitis, very serious blistering reactions including Stevens-Johnson syndrome (widespread erosions affecting the skin and at least two mucous membranes) and toxic epidermal necrolysis (erosions on mucous membranes and painful lesions with necrosis and shedding of the epidermis), erythema multiforme (skin lesion). Exceptionally, severe skin infections and soft tissue complications may occur during chickenpox. Liver failure (severe liver damage), heart failure, myocardial infarction, hypertension.
Exacerbation of inflammation-related infections has been observed with the use of NSAIDs. If signs of infection or worsening of symptoms occur during the use of ibuprofen, it is recommended to consult a doctor as soon as possible.
Frequency not known: (cannot be estimated from available data):
The skin becomes sensitive to light, exacerbation of colitis and Crohn's disease (chronic disease in which the immune system attacks the intestine, causing inflammation that usually produces bloody diarrhea).
A serious skin reaction known as DRESS syndrome (by its English acronym) may occur. The symptoms of DRESS syndrome include: skin rash, lymph node inflammation, and elevated eosinophils (a type of white blood cell).
Generalized red scaly rash, with bumps under the skin and blisters, mainly located in skin folds, trunk, and upper limbs, accompanied by fever at the start of treatment (acute generalized exanthematous pustulosis). Stop taking this medication if you experience these symptoms and seek medical attention immediately. See also section 2.
If any of the following adverse effects occur, interrupt treatment and seek medical attention immediately:
Reporting adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children.
No special storage conditions are required.
Validity period after opening: 6 months.
Do not use this medication after the expiration date shown on the container after "CAD". The expiration date is the last day of the month indicated.
Medications should not be thrown down the drain or into the trash. Deposit the containers and medications you no longer need at the SIGRE collection point in the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medications you no longer need. This way, you will help protect the environment.
Composition of Ibudol Pediatric
Appearance of Ibudol Pediatric and package contents
Viscous oral suspension, white or almost white in color, with a strawberry flavor and odor.
It is presented in plastic bottles of 30, 100, 150, and 200 mL. It includes a 5 mL dosing syringe graduated in milliliters.
Marketing authorization holder
Kern Pharma, S.L.
Venus, 72 - Pol. Ind. Colón II
08228 Terrassa - Barcelona
Spain
Manufacturer
Kern Pharma, S.L.
Venus, 72 - Pol. Ind. Colón II
08228 Terrassa - Barcelona
Spain
or
Edefarm, S.L.
Polígono Industrial Enchilagar del Rullo, 117
Villamarchante, Valencia, 46191,
Spain
or
Farmalider, S.A.
C/ Aragoneses 2,
28108 Alcobendas - Madrid
Spain
Date of the last revision of this prospectus: July 2024
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS)http://www.aemps.gob.es/.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for IBUDOL PEDIATRIC 40 mg/mL ORAL SUSPENSION – subject to medical assessment and local rules.